Estimated Absorbed Dose at Time of Calibration from 201Tl as Thallous Chloride Plus Contaminants After Intravenous Administration (Assumed Percentages of 201Tl, 200Tl, 202Tl, and 203Pb: 0.983, 0.003, 0.012, 0.002) and Percent Contribution of Each Radionuclide to Absorbed Dose
| Organ | Estimated radiation dose | % contribution | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rad/mCi | mGy/MBq, | |||||||||||||||||
| 201Tl | 200Tl | 202Tl | 203Pb | Total | Total | 201Tl | 200Tl | 202Tl | 203Pb | |||||||||
| Adrenals | 2.10E−01 | 2.18E−03 | 2.14E−02 | 8.34E−04 | 2.34E−01 | 6.33E−02 | 89.58 | 0.93 | 9.14 | 0.36 | ||||||||
| Brain | 1.91E−01 | 1.08E−03 | 1.77E−02 | 3.35E−04 | 2.10E−01 | 5.68E−02 | 90.88 | 0.51 | 8.45 | 0.16 | ||||||||
| Breasts | 1.15E−01 | 9.42E−04 | 9.64E−03 | 2.35E−04 | 1.25E−01 | 3.39E−02 | 91.38 | 0.75 | 7.68 | 0.19 | ||||||||
| GB wall | 2.75E−01 | 2.95E−03 | 2.80E−02 | 1.01E−03 | 3.07E−01 | 8.31E−02 | 89.60 | 0.96 | 9.11 | 0.33 | ||||||||
| LLI wall | 1.04E+00 | 4.88E−03 | 4.53E−02 | 3.19E−04 | 1.09E+00 | 2.96E−01 | 95.39 | 0.45 | 4.13 | 0.03 | ||||||||
| Small intestine | 1.34E+00 | 5.73E−03 | 5.32E−02 | 3.67E−04 | 1.40E+00 | 3.79E−01 | 95.77 | 0.41 | 3.80 | 0.03 | ||||||||
| Stomach wall | 5.95E−01 | 3.69E−03 | 3.47E−02 | 3.59E−04 | 6.34E−01 | 1.71E−01 | 93.89 | 0.58 | 5.47 | 0.06 | ||||||||
| ULI wall | 1.03E+00 | 6.35E−03 | 5.61E−02 | 4.08E−04 | 1.10E+00 | 2.97E−01 | 94.27 | 0.58 | 5.11 | 0.04 | ||||||||
| Heart wall | 8.74E−01 | 3.82E−03 | 3.49E−02 | 4.31E−04 | 9.14E−01 | 2.47E−01 | 95.71 | 0.42 | 3.82 | 0.05 | ||||||||
| Kidneys | 1.45E+00 | 6.37E−03 | 6.05E−02 | 1.68E−03 | 1.52E+00 | 4.10E−01 | 95.49 | 0.42 | 3.98 | 0.11 | ||||||||
| Liver | 3.19E−01 | 2.51E−03 | 2.29E−02 | 3.02E−03 | 3.47E−01 | 9.39E−02 | 91.80 | 0.72 | 6.61 | 0.87 | ||||||||
| Lungs | 1.59E−01 | 1.33E−03 | 1.40E−02 | 4.64E−04 | 1.75E−01 | 4.73E−02 | 90.98 | 0.76 | 8.00 | 0.27 | ||||||||
| Muscle | 1.53E−01 | 1.42E−03 | 1.44E−02 | 3.71E−04 | 1.70E−01 | 4.59E−02 | 90.46 | 0.83 | 8.49 | 0.22 | ||||||||
| Ovaries | 3.38E−01 | 3.72E−03 | 3.40E−02 | 3.43E−04 | 3.76E−01 | 1.02E−01 | 89.90 | 0.99 | 9.02 | 0.09 | ||||||||
| Pancreas | 2.49E−01 | 2.61E−03 | 2.57E−02 | 6.62E−04 | 2.78E−01 | 7.53E−02 | 89.59 | 0.94 | 9.23 | 0.24 | ||||||||
| Red marrow | 1.44E−01 | 1.68E−03 | 1.68E−02 | 1.31E−03 | 1.64E−01 | 4.44E−02 | 87.93 | 1.02 | 10.25 | 0.80 | ||||||||
| Bone surface | 3.18E−01 | 1.65E−03 | 2.06E−02 | 6.78E−03 | 3.47E−01 | 9.37E−02 | 91.62 | 0.48 | 5.95 | 1.96 | ||||||||
| Skin | 1.07E−01 | 8.42E−04 | 8.79E−03 | 2.45E−04 | 1.17E−01 | 3.16E−02 | 91.55 | 0.72 | 7.52 | 0.21 | ||||||||
| Spleen | 5.74E−01 | 3.39E−03 | 3.61E−02 | 3.18E−04 | 6.14E−01 | 1.66E−01 | 93.51 | 0.55 | 5.88 | 0.05 | ||||||||
| Testes | 7.38E−01 | 2.59E−03 | 3.15E−02 | 2.20E−04 | 7.73E−01 | 2.09E−01 | 95.56 | 0.34 | 4.08 | 0.03 | ||||||||
| Thymus | 1.54E−01 | 1.37E−03 | 1.42E−02 | 2.96E−04 | 1.70E−01 | 4.60E−02 | 90.69 | 0.81 | 8.33 | 0.17 | ||||||||
| Thyroid | 1.94E+00 | 5.31E−03 | 5.75E−02 | 2.84E−04 | 2.00E+00 | 5.42E−01 | 96.85 | 0.27 | 2.87 | 0.01 | ||||||||
| UB wall | 2.09E−01 | 1.94E−03 | 1.98E−02 | 2.56E−04 | 2.31E−01 | 6.25E−02 | 90.50 | 0.84 | 8.55 | 0.11 | ||||||||
| Uterus | 2.87E−01 | 3.03E−03 | 2.87E−02 | 3.05E−04 | 3.19E−01 | 8.64E−02 | 89.98 | 0.95 | 8.98 | 0.10 | ||||||||
| Total body | 1.96E−01 | 1.54E−03 | 1.59E−02 | 6.11E−04 | 2.14E−01 | 5.77E−02 | 91.56 | 0.72 | 7.43 | 0.29 | ||||||||
| Effective dose | % contribution | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rem/mCi | mSv/MBq, | ||||||||||||||||
| 5.42E−01 | 2.64E−03 | 2.70E−02 | 6.26E−04 | 5.73E−01 | 1.55E−01 | 94.70 | 0.46 | 4.72 | 0.11 | ||||||||
GB = gallbladder; LLI = lower large intestine; ULI = upper large intestine; UB = urinary bladder.
Effective dose and percent contribution to effective dose for each radioisotope are provided at bottom of table.